EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Sano Bruno's Enterprises Ltd (SANO1) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Sano Bruno's Enterprises Ltd ILS 290, price ILS 337, upside -13.8%, quality 56 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Consumer Defensive · Il · ISIN IL0008130143

SB Broad data Sep 23, 2026

Sano Bruno's Enterprises Ltd

SANO1 · TA

Overvalued / MonitorQuality is not strong enough to offset the price risk.

!Fair value 290.36 ILA · Overvalued (−14%)
!Quality 56/100
!Expensive Growth (revenue 5y +4.4 %/yr)
✓Solidly profitable · 13.1% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (9/14)
!Moderate moat 57/100
!Insider activity 30/100
!Weak on valuation: 15 out of 100
!Weak on future: 4 out of 100
Watch Sano Bruno's Enterprises Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

464.00 ILA 187.28 ILA Fair Value 290.36 ILA May 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range 187.28 ILA – 464.00 ILA · fair‑value band 179.10 ILA – 434.94 ILA · the 337.00 ILA price screens above the 290.36 ILA fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Sano Bruno's Enterprises in your weekly email

Every Wednesday you see whether Sano Bruno's Enterprises is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Sano Bruno's Enterprises Ltd, together with its subsidiaries, engages in the development, production, marketing, distribution, and sale of non-food household and commercial consumer products in Israel and internationally. It operates in four segments: Cleaning and Home Maintenance Products, Paper Products, Toiletries and Cosmetics, and Others.

Show more

Sano Bruno's Enterprises Ltd, together with its subsidiaries, engages in the development, production, marketing, distribution, and sale of non-food household and commercial consumer products in Israel and internationally. It operates in four segments: Cleaning and Home Maintenance Products, Paper Products, Toiletries and Cosmetics, and Others. The company offers mosquito repellents, insecticide killers, and pesticides; cooking and cleaning accessories, such as tools and floor cleaning, cooking and baking, and general cleaning accessories, as well as garbage and food bags; home cleaning products for floors, kitchen, toilets and bathtubs, handling mold and moisture, furniture, windows, and rugs, as well as general cleaning items and bleach products; laundry products comprising fabric softeners, stain removers, laundry fragrances, laundry supplies for babies, and auxiliary materials for laundry and ironing; dishwashing products; home fragrances; and cleaning agents and aids, detergents, washing powders, fabric and carpet care products, air fresheners, and renovation and maintenance products under the Sno brand. It also provides paper products, including toilet paper, handkerchiefs, napkins, paper and kitchen towels, and nose wipes under the Sno brand. In addition, the company offers toiletries and cosmetics comprising makeup, facial care, perfumery, shampoo and hair care, body care, deodorant, and spa products under the Carline, Crema, Natural Formula, Skin Guard, Neka, and Kif brands; baby care products under the Baby Fun brand; wet wipes for babies under the Litufim brand; and toothpastes and mouthwash under the Orbitol and Theadant brands. Further, it markets and distributes adult diapers under the Tena brand. Additionally, the company exports its products. Sano Bruno's Enterprises Ltd was founded in 1965 and is based in Hod HaSharon, Israel.

Stock analysis

Sano Bruno's Enterprises Ltd (SANO1) currently trades at 337.00 ILA, while our model-based Fair Value estimate is 290.36 ILA, implying the stock looks roughly 16.1% overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 442.74 ILA per share, and 9 of the 25 models we run sit above the 337.00 ILA price.

Bear case: the Dividend Discount group reads lowest at 76.74 ILA, and 16 of the 25 models stay below the price. Evidence for this calculation is high.

Scenario range: 179.10 ILA (bear) to 434.94 ILA (bull), the price of 337.00 ILA sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 56/100 (solid quality), in the Consumer Defensive sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Sano Bruno's Enterprises Ltd reported revenue of 2.2B ILS in FY2025 versus 1.8B ILS in FY2021, a compound +5.2%/yr. Reported net income was 282M ILS in FY2025, compounding +2.9%/yr from FY2021.

Key figures

Market cap 3.8B ILA · P/E ratio 12.9 · P/S ratio 1.62 · EPS (TTM) 26.13 ILA · Dividend yield 1.7% · Net margin 12.6% · Return on equity 13.4% · Return on assets (EBIT) 12.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).

What moves the price

The share trades about 27% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −25% fair-value upside, at −14%, SANO1 screens cheaper than that median.

Fair Value models

Bear 179.10 ILA Fair Value 290.36 ILA Bull 434.94 ILA
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (19.11 ILS per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 100.53 ILA 134.43 ILA 182.02 ILA 81
Growth DCF 102.09 ILA 132.79 ILA 173.68 ILA 80
Owner Earnings 155.85 ILA 214.99 ILA 298.00 ILA 77
All 25 models by family
DCF Models
FCF DCF 100.53 ILA 134.43 ILA 182.02 ILA 81
Owner Earnings 155.85 ILA 214.99 ILA 298.00 ILA 77
5Y Revenue Exit 177.87 ILA 281.53 ILA 412.78 ILA 72
5Y EBITDA Exit 241.43 ILA 396.80 ILA 575.06 ILA 74
5Y P/E Exit 272.67 ILA 453.45 ILA 638.72 ILA 70
10Y Revenue Exit 141.55 ILA 227.35 ILA 339.76 ILA 66
10Y EBITDA Exit 186.57 ILA 304.30 ILA 457.42 ILA 67
10Y P/E Exit 205.81 ILA 342.12 ILA 503.57 ILA 63
Earnings-Based
Graham-Dodd 170.73 ILA 451.21 ILA 589.46 ILA 65
PEG = 1.0 86.82 ILA 124.03 ILA 161.24 ILA 57
EPV 244.02 ILA 278.41 ILA 308.08 ILA 74
Dividend Discount
Gordon GGM 50.50 ILA 99.57 ILA 152.37 ILA 66
DDM Multi-Stage 50.50 ILA 76.74 ILA 103.67 ILA 66
Multiples
P/E Multiple 395.43 ILA 527.24 ILA 659.05 ILA 63
P/S Multiple 239.12 ILA 318.82 ILA 398.53 ILA 58
P/B Multiple 320.11 ILA 426.81 ILA 533.52 ILA 55
EV/EBIT 415.09 ILA 544.72 ILA 674.34 ILA 66
EV/EBITDA 365.21 ILA 478.21 ILA 591.21 ILA 67
EV/Revenue 235.44 ILA 325.11 ILA 414.77 ILA 54
Asset-Based
NCAV (Graham) 98.68 ILA 132.23 ILA 197.36 ILA 54
Growth DCF
Growth DCF 102.09 ILA 132.79 ILA 173.68 ILA 80
Rev-Margin DCF 177.87 ILA 280.38 ILA 392.23 ILA 72
Economic Profit
Residual Income 183.21 ILA 219.71 ILA 461.51 ILA 71
ROIC Compounder 251.47 ILA 303.64 ILA 363.43 ILA 72
Growth Earnings
Growth-Adj P/E 309.92 ILA 442.74 ILA 575.56 ILA 67

Open the full fair value analysis →

Notify me when SANO1 reaches fair value

Put SANO1 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 56/100

Of which business quality 58 · Market factors (momentum, volatility) 44

Profitability 58
Margins and returns on capital today
Quality Growth 33
Are margins and returns improving?
Cashflow 27
Earnings quality: real cash, not paper profit
Fin. Strength 87
Balance sheet, leverage, solvency risk
Investment 59
Disciplined investing over empire-building
Low Volatility 83
Calm price path (market factor)
Momentum 31
Price trend over the last 3–12 months (market factor)
52W Momentum 24
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 51/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−1.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.4%
Start year 2020 (pandemic). Over 10 years: +4.2% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.8%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+7.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.5%
Dividend (yield on the price)1.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.6% vs 9%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 15%
Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+24.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Israel: IMF forecast 2.1% a year to 2030, 1.7% from 2016 to 2025) that is about +21.9% a year for the price.

SANO1 screens 16% overvalued. Compare with The Procter & Gamble Company →

Compare Sano Bruno's Enterprises Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 246 stocks

Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 56 · Below median
Fair Value upside −16% · Below median
Profitability
Return on equity (TTM) 13% · Above median
Return on assets 8% · Top 25%
Net margin (TTM) 13% · Top 25%
Operating margin (TTM) 16% · Top 25%
Growth and dividend
Revenue growth 1% · Below median
Dividend yield (TTM) 1.7% · Below median

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/E (TTM) 12.9× · Cheaper than median
P/B 0.58× · Cheaper than median
P/S (TTM) 0.58× · Cheaper than median
P/FCF 16.4× · Priciest 25%
EV/EBITDA 2.6× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)15 · sector 33
FUTURE (revenue growth)4 · sector 9
PAST (return on equity)54 · sector 27
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)34 · sector 55

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $148.22 $110.45 −25%
Colgate-Palmolive Company CL $87.05 $55.95 −36%
Hindustan Unilever Limited HINDUNILVR ₹1,934 ₹799.52 −59%
Kenvue Inc KVUE $17.86 $12.73 −29%
Kimberly-Clark Corporation KMB $98.91 $83.93 −15%
Henkel AG HEN €69.30 €80.96 +17%
The Estée Lauder Companies Inc EL $100.29 $27.22 −73%
Church & Dwight Co CHD $96.12 $65.12 −32%
Beiersdorf Aktiengesellschaft, BEI €76.46 €68.95 −10%
Puig Brands, S.A PUIG €17.56 €19.32 +10%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Sano Bruno's Enterprises Ltd · Fair Value
290.36 ILA −16%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Sano Bruno's Enterprises Ltd Fair Value". https://www.fairvalue-calculator.com/stock/SANO1

Frequently asked questions

Is Sano Bruno's Enterprises Ltd (SANO1) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 290.36 ILA versus a price of 337.00 ILA, about −14% upside (overvalued).
What is the fair value of SANO1?
Our model-based fair value for Sano Bruno's Enterprises Ltd is 290.36 ILA (as of Sep 23, 2026), built from audited fundamentals. The current price: 337.00 ILA.
What is the quality score of SANO1?
Sano Bruno's Enterprises Ltd has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sano Bruno's Enterprises Ltd (SANO1)?
Our model-based price target is the fair value of 290.36 ILA (as of Sep 23, 2026) from 25 valuation models. Cautious scenario 179.10 ILA, optimistic scenario 434.94 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the Sano Bruno's Enterprises Ltd stock forecast for 2026?
Our models put fair value at 290.36 ILA, about −14% upside versus a price of 337.00 ILA (overvalued). Cautious scenario 179.10 ILA, optimistic scenario 434.94 ILA. The calculation is refreshed regularly with new filings.
What is the revenue of Sano Bruno's Enterprises Ltd (SANO1)?
Sano Bruno's Enterprises Ltd reported trailing-twelve-month revenue of about 2.2B ILS (latest available figure, as of Sep 23, 2026).
Does Sano Bruno's Enterprises Ltd pay a dividend?
Sano Bruno's Enterprises Ltd currently shows a dividend yield of about 1.71% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Sano Bruno's Enterprises Ltd (SANO1)?
For today's price to be fair in a discounted-cash-flow model, Sano Bruno's Enterprises Ltd would have to grow free cash flow by +24.4 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.4 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of SANO1 use?
Our models discount Sano Bruno's Enterprises Ltd at 10.1 %: a base by market capitalisation (mid), damped by beta 0.19, country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Sano Bruno's Enterprises Ltd that is +24.4 % per year a year over ten years, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has Sano Bruno's Enterprises Ltd (SANO1) delivered so far?
Over the past 5 years revenue at Sano Bruno's Enterprises Ltd grew +4.4 % a year. The price currently implies +24.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Sano Bruno's Enterprises Ltd (SANO1) growing?
The median revenue growth in the sector is +2.7 % a year. That is the yardstick for the growth priced into Sano Bruno's Enterprises Ltd (+24.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Sano Bruno's Enterprises Ltd (SANO1)?
The free-cash-flow yield on the price is 2.08 %: that much free cash flow Sano Bruno's Enterprises Ltd produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Sano Bruno's Enterprises Ltd (SANO1)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sano Bruno's Enterprises Ltd it is 290.36 ILA per share (as of Sep 23, 2026), against a price of 337.00 ILA. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is Sano Bruno's Enterprises Ltd stock overvalued or undervalued in 2026?
As of Sep 23, 2026, SANO1 trades above its calculated fair value: price 337.00 ILA, fair value 290.36 ILA, a gap of about −14% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SANO1?
No. The price is what the market pays today (337.00 ILA); the fair value is what the company's own numbers justify (290.36 ILA). For Sano Bruno's Enterprises Ltd the two are 46.64 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is Sano Bruno's Enterprises Ltd worth?
The market values Sano Bruno's Enterprises Ltd at about 3.8B ILA (market capitalisation, as of Sep 23, 2026). Per share that is 337.00 ILA; our models calculate a fair value of 290.36 ILA per share.
What do the bullish and bearish scenarios say about SANO1?
Our models span a range for Sano Bruno's Enterprises Ltd: cautious scenario 179.10 ILA, base 290.36 ILA, optimistic 434.94 ILA per share (as of Sep 23, 2026, price 337.00 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SANO1?
Sano Bruno's Enterprises Ltd trades at a price-to-earnings ratio of 12.9 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 290.36 ILA is built from several models across several years. Other multiples: P/B 0.6, P/S 0.6, EV/EBITDA 2.6.
How solid is the balance sheet of Sano Bruno's Enterprises Ltd (SANO1)?
Balance-sheet figures for Sano Bruno's Enterprises Ltd (as of Sep 23, 2026): return on equity 13.4%. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is SANO1 from its 52-week high?
Sano Bruno's Enterprises Ltd trades at 337.00 ILA, about 27% below its 52-week high of 464.00 ILA and 5% above the low of 320.87 ILA (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 290.36 ILA is for.
Which stocks are comparable to Sano Bruno's Enterprises Ltd?
From the same area (Consumer Defensive) we also value The Procter & Gamble Company, Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sano Bruno's Enterprises Ltd stock attractive at the current price?
The data as of Sep 23, 2026: price 337.00 ILA, calculated fair value 290.36 ILA (−14%), Quality Score 56/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SANO1 calculated?
We run Sano Bruno's Enterprises Ltd through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 290.36 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Sano Bruno's Enterprises Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sano Bruno's Enterprises Ltd (SANO1)?
The closing price on Sep 23, 2026 was 337.00 ILA. Our model-based fair value is 290.36 ILA, about −14% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sano Bruno's Enterprises Ltd right now?
Solid but not exceptional quality (56/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (179.10 ILA to 434.94 ILA) leaves room in how you read the outcome.
Where does the earnings growth of Sano Bruno's Enterprises Ltd (SANO1) come from?
Earnings per share at Sano Bruno's Enterprises Ltd grew +8.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share +4.5 %, EBIT margin +1.5 %, tax rate +0.8 %, residual (interest, one-offs) +1.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Sano Bruno's Enterprises Ltd

How large is the market capitalisation of Sano Bruno's Enterprises Ltd (SANO1)?
The market capitalisation of Sano Bruno's Enterprises Ltd is 3.8B ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sano Bruno's Enterprises Ltd (SANO1)?
The price-to-sales ratio of Sano Bruno's Enterprises Ltd is 1.62 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sano Bruno's Enterprises Ltd (SANO1)?
Earnings per share at Sano Bruno's Enterprises Ltd are 26.13 ILA (price ÷ EPS = P/E 12.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Sano Bruno's Enterprises Ltd (SANO1)?
The dividend yield of Sano Bruno's Enterprises Ltd is 1.7% (payout 22.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Sano Bruno's Enterprises Ltd (SANO1)?
The net margin of Sano Bruno's Enterprises Ltd is 12.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sano Bruno's Enterprises Ltd (SANO1)?
The return on equity (ROE) of Sano Bruno's Enterprises Ltd is 13.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sano Bruno's Enterprises Ltd (SANO1)?
On an EBIT basis the return on assets of Sano Bruno's Enterprises Ltd is 12.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sano Bruno's Enterprises Ltd (SANO1)?
The operating margin of Sano Bruno's Enterprises Ltd is 15.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sano Bruno's Enterprises Ltd (SANO1)?
Revenue at Sano Bruno's Enterprises Ltd is growing +0.8% versus a year earlier (3y avg +5.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sano Bruno's Enterprises Ltd (SANO1)?
Earnings per share at Sano Bruno's Enterprises Ltd are growing +16.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Sano Bruno's Enterprises Ltd (SANO1) hold?
Sano Bruno's Enterprises Ltd holds more cash than debt, 256M ILA net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Sano Bruno's Enterprises Ltd in the live analysis

One click puts Sano Bruno's Enterprises Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.